Retinopathy of prematurity (ROP), a vasoproliferative retinal disease affecting premature infants, is a leading cause of childhood blindness throughout the world. Plus disease, defined as venous dilatation and arteriolar tortuosity within the posterior retinal vessels greater than or equal to that of a standard published photograph, is the most critical finding in identifying treatment-requiring ROP. Despite an internationally accepted definition of plus disease, there is significant variability in diagnostic process and outcome, producing variable levels of reported intra-and interexpert agreement. Several potential explanations for poor agreement have been proposed, including attention to undefined vascular features such as venous tortuosity, focus on narrower or wider field of view, unfamiliarity with digital images, the magnification and apparent severity of the standard photograph, and cut-off point differences among experts as to the level of tortuosity and dilation sufficient for "plus disease" along a continuum. Moreover, differences in diagnostic consistency among groups of experts separated both geographically and chronologically have been reported. These findings have implications for clinical care, research, and education, and highlight the need for a more precise definition of plus disease and objective diagnostic methods for ROP.
R etinopathy of prematurity (ROP) is a vasoproliferative process affecting premature infants and is a leading cause of childhood blindness. Accurate and timely diagnosis of the disease is important to guide potentially vision-saving treatment. The presence of plus disease has been shown to be the most critical factor for the diagnosis of severe, treatment-requiring disease according to the Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) and the Early Treatment of Prematurity (ETROP) trials.
1,2 The ETROP study calls for treatment of "type 1 ROP," which includes any ROP in zone I with plus disease, stage 2 or 3 in zone II with plus disease, along with stage 3 in zone I without plus disease. 2 The presence of plus disease is an indicator of the severity of activity of ROP and is an important prognostic indicator. 3 The CRYO-ROP study found that the presence of plus disease was a risk factor for unfavorable macular and anatomical outcomes. 3 Wallace et al 4 demonstrated that even pre-plus vascular changes have increased risk of progressing to higher stages of disease and need for treatment. As an integral part of treatmentdefining disease, accurate diagnosis of plus disease is important in the screening of ROP. Currently, plus disease is defined by a standard published photograph selected by expert consensus in the 1980s that details a minimum amount of venous dilation and arterial tortuosity required to make the diagnosis. 5 An update to the diagnostic criteria in 2005 expanded the classification to a 3-level scale by introducing the term pre-plus, an intermediate level of vascular dilation and tortuosity between that of normal and plus disease. 6 Because diagnosis of plus disease is based on subjective qualitative features, there has been discussion about the variability of diagnosis among providers and how to create a more standardized way to diagnose plus disease. The purpose of this article is to review interexpert disagreement in plus disease, to summarize areas in which expert diagnosis of plus disease is inconsistent with published definitions, and to explore future avenues for improving the precision, accuracy, and objectivity of plus disease diagnosis.
VARIABILITY IN DIAGNOSIS OF PLUS DISEASE
There have been multiple studies looking at interexpert and intraexpert agreement on plus disease diagnosis and analyzing what retinal features experts use in their diagnostic process. [7] [8] [9] [10] [11] Various definitions for "expert" have been used in different studies, but general criteria have been set in terms of years of practice, authorship and/or leadership in ROP research, and participation in clinical trials. There are 2 ways the studies have reported agreement: percent agreement and the kappa statistic. In ROP, when the vast majority of infants have none or very mild disease, percent agreement can be misleading. Thus, many of the following studies used kappa values to measure agreement among experts, which measure the difference from the observed agreement and the expected agreement from chance alone. The values range from −1.00, which indicates perfect disagreement, to +1.00, which indicates perfect agreement, with a value of 0 indicating the level of agreement that would be expected due to chance. A value of 0.00-0.20 is accepted as slight agreement, 0.21-0.40 as fair agreement, 0.41-0.60 as moderate agreement, 0.61-0.80 as substantial agreement, and 0.81-1.00 as almost perfect agreement. 12 The kappa values are difficult to compare across studies as they depend on the characteristics of the data set, but they can give valuable information within the particular study. Overall, imperfect agreement on diagnosis has been shown and there have been a number of potential explanations considered in the literature.
Variability in Diagnostic Outcome

Intragrader Agreement
Gschließer et al 7 showed that the diagnosis of plus disease can differ by 1 expert when presented with the same image on different days, indicating there are issues with reproducibility of diagnosis. In the study, 260 widefield digital photographs of 52 patients from Austria were presented to 7 ROP experts on 2 consecutive assessments 8 weeks apart. Intraexpert agreement was moderate for ROP stage (κ = 0.56) and plus disease (κ = 0.51), moderate for necessity for treatment (κ = 0.47), and substantial for kind of treatment (κ = 0.63).
7
Intergrader Agreement
The paper by Gschließer et al 7 also demonstrated the discrepancy in interexpert agreement. Interexpert agreement was fair for diagnosis of plus disease (κ = 0.32), moderate for necessity for treatment (κ = 0.41), and fair for kind of treatment (κ = 0.38). 7 Various other papers also presented images to a varying number of graders in attempts to determine agreement of experts in diagnosis of plus disease. In a study by Chiang et al, 8 34 images were reviewed by 22 experts from the United States. The mean weighted κ statistic ranged from 0.25 to 0.55 (fair to moderate agreement). Using 3 level categorization of normal, pre-plus, and plus, all 22 experts agreed on the same diagnosis only in 12% of images (4 of 34). 8 In another study by Slidsborg et al, 9 there was poor interexpert agreement on severity of central vascular changes (7.4%) among 4 readers from the United Kingdom, Sweden, and Denmark. In this paper, the eye was divided into quadrants and each quadrant was independently graded. Readers agreed on the scores of only 70 of 948 total quadrants, but there was higher rate of agreement when deciding if treatment was indicated. 9 Wallace et al 10 demonstrated that among 3 graders, there was disagreement on plus disease for 18 images (27%), on tortuosity sufficient for plus disease for 25 images (37%), and on dilation sufficient for plus disease for 21 images (31%). If excluding normal images, there was disagreement on plus disease for 18 of 67 images (27%). In a U.S. study by Campbell et al, 11 2 experts interpreted images according to zone, stage, plus, and overall disease category. The 2 experts disagreed on plus disease classification in 18% of study examinations. This paper was important in that it also showed that there was no difference between diagnosis made based on imaging versus indirect ophthalmoscopy examination for plus disease, a common source of controversy in research involving ROP images.
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Geographic Variation
There also seems to be geographic disagreement in plus disease diagnosis. A study to investigate the international differences in ROP treatment rate within the Benefits of Oxygen Saturation Targeting II trials found that U.K. ophthalmologists diagnosed plus disease more frequently than ophthalmologists from Australia and New Zealand. 13 
Temporal Drift in Diagnosis
In addition to overall disagreement of diagnosis among experts, there has been a temporal shift in diagnosis. In a U.S. study by Moleta et al, 14 separate groups of ROP experts classified the same set of retinal images in 2007 and 2016. The study showed that experts were diagnosing pre-plus and plus disease at earlier stages of disease severity in 2016 compared with 2007. This has important considerations regarding timing of treatment and additional studies are warranted to explore possible causes for the evolving diagnostic trend and its possible influences on treatment outcome.
Variability in Diagnostic Process
Multiple studies have attempted to look at the underlying diagnostic reasoning process of experts to determine why there is such variability in outcome and to elucidate the true features experts consider in their diagnosis and how they differ from the standard photograph.
Underlying Diagnosis Reasoning Process
Hewing et al 15 presented 7 wide-angle retinal images to 6 experts and recorded their reasoning process while thinking aloud. The study showed low interexpert correlation for overall disease severity and variability in intraexpert agreement, indicating that experts seem to consider different retinal features and interpret the same features differently.
15
Field of View
The standard published photograph of the original International Classification of Retinopathy of Prematurity (ICROP) includes only a narrow field of view of about 2-3 disc diameters. However, studies suggest that experts consider larger retinal fields of view. Rao et al 16 specifically looked at how retinal field of view and magnification affected the consistency of diagnosis of plus disease. The study showed that there was higher interexpert agreement in diagnosis when using wide-angle images, suggesting that peripheral retinal features are considered by experts during clinical plus disease diagnosis. 16 This was further confirmed in the study by Hewing et al 15 in which some experts cited peripheral retinal vascular features as part of their diagnosis of plus disease in their thinking aloud process. Campbell et al 17 further demonstrated that the Imaging and Informatics in ROP (i-ROP) computer-based image analysis (CBIA) system was more accurate in identifying plus disease when evaluating larger fields of view. In a study looking at vascular tortuosity as a function of distance from the optic nerve, it was shown that there is an increase in vascular tortuosity peripherally compared with centrally, suggesting that these peripheral retinal features are relevant for the diagnosis of plus disease.
ICROP in 2005. 6 However, it is not clear whether plus disease diagnosis should be performed using a "quadrant-based" (ie, diagnose each quadrant individually and integrate findings into an overall diagnosis) or an "eye-based" (ie, assess overall retinal appearance) method. Wallace et al 10 compared expert diagnosis using quadrant-based grades, and some experts in Hewing et al 15 mentioned using the number of quadrants of abnormality in their decision-making process. A recent study compared intra-and intergrader agreement and accuracy of eye-versus quadrant-based diagnosis for plus disease. 20 In this study, graders independently diagnosed each of the 4 cropped quadrant images (quadrant-based diagnosis), along with the entire image (eye-based diagnosis). This study showed that intragrader agreement between eye-and quadrant-based diagnosis is limited, intergrader agreement with quadrant-based diagnosis was lower than with eye-based diagnosis, and diagnostic accuracy with quadrant-based diagnosis was lower than with eye-based diagnosis. 20 These findings suggest that eye-based diagnosis may have advantages over quadrant-based diagnosis regarding reliability and accuracy and that more precise definitions of plus disease regarding criterion of at least 2 quadrants will provide additional diagnostic standardization. Additionally, with regard to CBIA, this study suggested that deductive computer-based algorithms that are eye-based, rather than quadrant-based, may be more successful.
Selection of Pathologic Vascular Features
The experts in Hewing et al 15 were also shown to consider retinal features beyond the standard definition of arteriolar tortuosity and venous dilation and mentioned quadrants of abnormality, peripheral vessels, and venous tortuosity in addition to other features. Campbell et al 17 also showed that accuracy of a CBIA system improved when considering vascular tortuosity from both arteries and veins and indicated that experts also consider tortuosity of both arteries and veins. Another study by Ataer-Cansizoglu et al 21 further characterized the causes of disagreement among experts by analyzing relationships between extracted vascular features computed from retinal images and expert diagnosis and showed that experts consider the amount of tortuosity along with the variation of tortuosity in an image and that venous tortuosity was also an important diagnostic feature.
Level of Pathologic Vascular Features
Campbell and Kalpathy-Cramer 22 analyzed the pattern of responses from 8 experts in 2 datasets and compared their classifications of the images into normal, pre-plus, and plus against a reference standard diagnosis based on 3 other independent graders and the clinical examination results. The study showed that experts seem to have different cut-off points for the border between the diagnosis of normal versus pre-plus and pre-plus versus plus and suggested that a continuous severity score instead of discrete classifications may more accurately reflect the true clinical behavior of experts and of the range of the vascularity abnormalities present in ROP. 22 The same group went on to further look at this trend by having experts compare 2 images at a time and then creating a relative ranking of those images. They showed that there was strong agreement among experts in the relative ordering of disease severity despite having poor agreement on absolute diagnostic classification. 23 This also suggests that a continuous severity score may improve agreement in plus disease diagnosis.
FUTURE DIRECTIONS: HOW CAN WE IMPROVE DIAGNOSIS?
Insofar as the diagnosis of plus disease remains subjective, a degree of interobserver disagreement is inevitable, and thus there have been a number of strategies employed to add objectivity to the diagnosis. The development of widefield fundus cameras for use in the neonatal population enabled research into quantitative CBIA programs in ROP. 24 Other studies have looked into the use of structural imaging modalities such as optical coherence tomography (OCT) and OCT angiography to aid in identifying early retinal and vascular features that correlate with disease severity or by identifying pathology not evident on clinical examination. [25] [26] [27] A study on 3-dimensional analysis of vascular abnormalities in handheld spectral domain OCT (SD-OCT) images presented unique vascular and perivascular SD-OCT features associated with plus disease, suggesting a more objective way of assessing plus disease using SD-OCT. 26 Preliminary results for CBIA and structural imaging in the evaluation of plus disease are in general promising but in need of further development, validation, and wider availability of the technologies.
The complexity, efficacy, and utility of CBIA programs are varied. Basic quantitative feature extraction programs, such as ROPTool, define explicit features, such as dilation and tortuosity, and quantify those features into a score. Abbey et al 28 recently published the results of the ROPTool compared with an expertderived score of plus disease severity (each of 4 experts ranked an image from 0 to 4, producing a ground truth score of 0 to 16). The ROPTool demonstrated an area under the receiver operating characteristic curve of 0.92 for detection of eyes with a score greater than 0/16. 28 The i-ROP research consortium has developed both a machine learning CBIA program, i-ROP ASSIST, 17, 29 and a deep learning program. 30 The i-ROP ASSIST program uses defined features for tortuosity and dilation to train a classifier that is able to perform as well as experts for the diagnosis of plus disease, but requires manually segmented images as inputs, 17 and can generate a continuous severity score as an output that corresponds well to the spectrum of plus disease. 22, 23 An automated plus disease diagnostic system using deep convolutional neural network (i-ROP DL) was recently introduced. Brown et al 30 trained a convolutional neural network using over 5000 retinal photographs taken from premature infants for ROP screening. The algorithm was evaluated by 5-fold cross-validation and tested on an independent set of 100 retinal images. Mean area under the receiver operating characteristic curve statistics of the algorithm were 0.94 for the diagnosis of normal (versus pre-plus disease or plus disease) and 0.98 for the diagnosis of plus disease (versus normal or pre-plus disease). In an independent test set of 100 images, the algorithm achieved a sensitivity of 93% with 94% specificity. For detection of pre-plus disease or worse, the sensitivity and specificity were 100% and 94%, respectively. Moreover, on the same test set, the algorithm diagnosed 91 of 100 images correctly compared with reference standard diagnosis, whereas 8 experts in ROP had an average accuracy of 82%. These results suggest that deep learning may enable automated screening for plus disease in ROP with high accuracy.
